ArticleOncotarget2015

JNJ-26481585 primes rhabdomyosarcoma cells for chemotherapeutics by engaging the mitochondrial pathway of apoptosis.

Ulrike Heinicke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.